Relationship between the effect of interferon therapy and the change of hepatitis C virus non-structural 5B gene

被引:14
|
作者
Horiike, N [1 ]
Michitaka, K [1 ]
Masumoto, T [1 ]
Okura, I [1 ]
Akbar, SMF [1 ]
Onji, M [1 ]
机构
[1] Ehime Univ, Sch Med, Dept Internal Med 3, Matsuyama, Ehime 7910295, Japan
关键词
hepatitis C virus; interferon; non-structural; 5B;
D O I
10.1046/j.1440-1746.1999.01859.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Hepatitis C virus (HCV)-RNA titre has been regarded as a factor affecting the response to interferon (IFN) therapy of patients with chronic hepatitis C (CHC). The focus of our study is the investigation of the nucleotide sequence of HCV-RNA NS5B, which may code RNA-dependent RNA polymerase and NS5A in the sera of 33 patients with CHC prior to IFN therapy. Methods: Hepatitis C virus genotype and HCV-RNA titre were examined by polymerase chain reaction (PCR) and competitive reverse transcriptase-PCR. Results: The sequence for HCV-RNA NS5B (nt 8331-8600 in Ib and 8410-8679 in 2a) was determined by direct sequencing. The changes of the predicted amino acids in the genotype-specific sites of HCV-J, HCV-BK, HC-J4/83, HCV-JT, HCV-N, HC-J6 and HCV-K2a were examined, and the mutation was defined when changes of amino acids in sites specific to different reported genotypes were revealed. The mutations were observed in 6/19 (32%) in genotype Ib and 9/14 (64%) in 2a. In the Ib group, complete response (CR) was achieved in 5/6 of the mutant and in 2/13 of the wild type groups (P< 0.05). No relationship was observed between IFN effectiveness and HCV-RNA titre in the Ib wild type group. In the 2a group, CR was achieved in 4/9 of the mutant and in 4/5 of the wild type groups. An inverse relationship between IFN responsiveness and HCV-RNA titre was apparent in Ib mutant, 2a wild and 2a mutant. Conclusions: These data suggest the possible relationship between changes in the HCV-NS5B gene and the effect of IFN therapy in CHC patients with genotype 1b.
引用
收藏
页码:345 / 351
页数:7
相关论文
共 50 条
  • [1] Relationship between interferon therapy and variability in nonstructural gene 5b of hepatitis C virus
    Tao, QM
    Wei, L
    Chang, JH
    Wang, H
    Sun, Y
    JOURNAL OF GASTROENTEROLOGY, 1998, 33 (05) : 684 - 693
  • [2] Relationship between interferon therapy and variability in nonstructural gene 5b of hepatitis C virus
    Qimin Tao
    Lai Wei
    Jinhong Chang
    Hao Wang
    Yan Sun
    Journal of Gastroenterology, 1998, 33 : 684 - 693
  • [3] Differential effect of interferon therapy on hepatitis C virus 1b quasispecies in the non-structural 5A gene.
    Sakuma, I
    Enomoto, N
    Asahina, Y
    Kurosaki, M
    Marumo, F
    Sato, C
    GASTROENTEROLOGY, 1997, 112 (04) : A1371 - A1371
  • [4] Expression of recombinant hepatitis C virus non-structural protein 5B in Escherichia coli
    Al, RH
    Xie, YP
    Wang, YH
    Hagedorn, CH
    VIRUS RESEARCH, 1998, 53 (02) : 141 - 149
  • [6] The global origins of resistance-associated variants in the non-structural proteins 5A and 5B of the hepatitis C virus
    Jones, Bradley R.
    Howe, Anita Y. M.
    Harrigan, P. Richard
    Joy, Jeffrey B.
    VIRUS EVOLUTION, 2018, 4 (01)
  • [7] Prediction of Hepatitis C Virus Non-Structural Proteins 5B Polymerase Inhibitors Using Machine Learning Methods
    Lue Wei
    Xue Ying
    ACTA PHYSICO-CHIMICA SINICA, 2011, 27 (06) : 1407 - 1416
  • [8] Hepatitis C virus non-structural 5B protein interacts with cyclin A2 and regulates viral propagation
    Pham, Long V.
    Ngo, Huong T. T.
    Lim, Yun-Sook
    Hwang, Soon B.
    JOURNAL OF HEPATOLOGY, 2012, 57 (05) : 960 - 966
  • [9] Correlation of the 5' untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping
    Baclig, Michael O.
    Chan, Veronica F.
    Ramos, John Donnie A.
    Gopez-Cervantes, Juliet
    Natividad, Filipinas F.
    INTERNATIONAL JOURNAL OF MOLECULAR EPIDEMIOLOGY AND GENETICS, 2010, 1 (03): : 236 - 244
  • [10] The non-structural 5A protein of hepatitis C virus
    Pawlotsky, JM
    Germanidis, G
    JOURNAL OF VIRAL HEPATITIS, 1999, 6 (05) : 343 - 356